Altimmune (ALT) Treasury Shares (2016 - 2018)

Altimmune (ALT) has reported Treasury Shares for 15 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 105.06% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 105.06% YoY), while the FY2025 annual figure was $2.1 million, up 140.45% from the prior year.
• Treasury Shares climbed to $2.2 million in Q1 2026 per ALT's latest filing, from $2.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.2 million in Q1 2026 and bottomed at $414485.0 in Q4 2022.
• Historically, Treasury Shares has averaged $885956.3 across 5 years, with a median of $784227.0 in 2024.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 460.11% — and 2025, when it advanced 16.65%.
• Altimmune's Treasury Shares stood at $414485.0 in 2022, then jumped by 45.76% to $604167.0 in 2023, then soared by 42.06% to $858290.0 in 2024, then surged by 140.45% to $2.1 million in 2025, then increased by 4.66% to $2.2 million in 2026.
• Business Quant data shows ALT's Treasury Shares at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $1.1 million in Q3 2025.